ClinicalTrials.Veeva

Menu

Assessment of CSF Shunt Flow During Activities of Daily Living and Sleep With a Thermal Measurement Device

Rhaeos logo

Rhaeos

Status

Not yet enrolling

Conditions

Hydrocephalus

Treatments

Device: wireless thermal anisotropy measurement device

Study type

Interventional

Funder types

Industry
NIH

Identifiers

NCT07050628
2025-03
5UG3NS130338 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

This study evaluates the performance of a device for non-invasively assessing cerebrospinal fluid (CSF) shunt flow over multiple measurements performed by a study subject during activities of daily living and sleep

Enrollment

20 estimated patients

Sex

All

Ages

5 to 21 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Existing ventricular CSF shunt
  2. (Cohort A) A history of stable ventricular size, no shunt revision in the previous 2 years, and no current symptoms of shunt failure
  3. (Cohort B) A shunt revision in the previous 7 days and the investigator judges that the patient will likely be discharged within 4 days of the enrollment date
  4. Region of intact skin overlying an unambiguously identifiable palpable chronically indwelling ventricular shunt which crosses the clavicle and is appropriate in size for application of the study device
  5. Signed informed consent by subject or a parent, legal guardian, health care agent, or surrogate decision maker (according to local statutes)
  6. Subject is at least 5 years old but < 22 years old

Exclusion criteria

  1. Shunt is not palpable or depth of shunt where the device will be placed is greater than 4 mm per ultrasound evaluation
  2. Presence of an interfering open wound or edema in the study device measurement region
  3. Subject-reported history of serious adverse skin reactions to silicone-based adhesives
  4. Investigator judges that the subject is likely to be lost to follow-up due to unavailability or clinical outcome being unobtainable
  5. Investigator judges that the subject is unlikely to successfully take reliable measurements at home
  6. Investigator judges that the subject/subject's caretaker would not be able to successfully place the device without assistance
  7. Use of the study device would interfere with standard patient care, or emergency surgery that cannot be delayed, or participation in the study will interfere with, or be detrimental to, administration of optimal healthcare to the subject
  8. Prior enrollment in this study
  9. Participation in any other investigational procedural, pharmaceutical, and/or device study that may influence the collection of valid data under this study

Trial design

Primary purpose

Basic Science

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

20 participants in 2 patient groups

No Recent Revision
Experimental group
Description:
Pediatric hydrocephalus patients with an existing ventricular CSF shunt and a history of stable ventricular size, no shunt revision in the previous 2 years, and no current symptoms of shunt failure will be enrolled.
Treatment:
Device: wireless thermal anisotropy measurement device
Recent Revision
Experimental group
Description:
Pediatric hydrocephalus patients with an existing ventricular CSF shunt and a shunt revision in the previous 7 days who the investigator judges will likely be discharged within 4 days of the enrollment date will be enrolled.
Treatment:
Device: wireless thermal anisotropy measurement device

Trial contacts and locations

1

Loading...

Central trial contact

Anna Somera

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems